WUHAN LL SCIENCE AND TECH DEVELOPMENT CO LTD has a total of 35 patent applications. It decreased the IP activity by 41.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are EGIS GYÓGYSZERGYÁR ZRT, BRIGHTSEED INC and ELCELYX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 18 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | United States | 8 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Wang Chaodong | 35 |
#2 | Chen Yongkai | 35 |
#3 | Feng Wei | 17 |
#4 | Lei Sijun | 11 |
#5 | Qian Lina | 10 |
#6 | Zeng Xian | 9 |
#7 | Liu Li | 8 |
#8 | Lou Jun | 8 |
#9 | Fang Xiang | 8 |
#10 | Hu Liu | 7 |
Publication | Filing date | Title |
---|---|---|
WO2021063207A1 | Jnk inhibitor, and pharmaceutical composition and use thereof | |
WO2019085983A1 | Method for preparing benzimidazole derivative with low impurity content | |
US2020055812A1 | Ammonium carboxylate compound, crystalline form, amorphous form and preparation method thereof | |
US2019382375A1 | Triazole antimicrobial derivative, pharmaceutical composition and use thereof | |
WO2018064945A1 | Pharmaceutical composition | |
EP3482747A1 | Complex disintegrant system for oral solid preparation and oral solid preparation comprising said complex disintegrant system |